# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA699379 | F | In vitro cytotoxicity against mouse J774 macrophages. | Mus musculus | 17 | cell-based format | Scientific Literature | ||
2. | ALA712524 | F | Inhibitory activity against Leishmania donovani amastigotes | Leishmania donovani | 7 | organism-based format | Scientific Literature | ||
3. | ALA712526 | F | Inhibitory activity against Leishmania donovani promastigotes | Leishmania donovani | 15 | organism-based format | Scientific Literature | ||
4. | ALA712536 | F | Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro | Leishmania donovani | 33 | organism-based format | Scientific Literature | ||
5. | ALA706588 | F | Percentage inhibition against Leishmania tubulin in vitro was determined at 20 uM | Leishmania sp. | 14 | organism-based format | Scientific Literature | ||
6. | ALA720631 | F | Tested against Trypanosoma brucei strain ST1B 795 in mice as cured to tested at 20 mg/kg/day administered intraperitoneally; 0/4 | Mus musculus | 4 | organism-based format | Scientific Literature | ||
7. | ALA726136 | F | Average survival time for mice infected with Trypanosoma brucei ST1B 795 when treated with 20 mg/kg administered i.p. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
8. | ALA873865 | F | In vitro cytotoxicity against mouse PC3 prostate cancer cell line. | Mus musculus | 16 | cell-based format | Scientific Literature | ||
9. | ALA811797 | T | Tested for toxicity against mice by intraperitoneal administration; No signs of toxicity | Mus musculus | 1 | assay format | Scientific Literature | ||
10. | ALA817527 | B | Inhibition of Leishmanial tubulin assembly | Leishmania donovani | 3 | assay format | Scientific Literature | ||
11. | ALA817529 | B | Inhibition percentage of Leishmanial tubulin assembly at a concentration of 10 uM. | Leishmania donovani | 16 | assay format | Scientific Literature | ||
12. | ALA820475 | B | Inhibition of porcine brain tubulin assembly at 40 uM | Sus scrofa | 14 | assay format | Scientific Literature | ||
13. | ALA881592 | F | Inhibitory concentration against brucei variant 221 was determined in vitro | Trypanosoma brucei | 34 | organism-based format | Scientific Literature | ||
14. | ALA1216999 | F | Antimicrobial activity against Trypanosoma brucei brucei | Trypanosoma brucei brucei | 251 | organism-based format | Scientific Literature | ||
15. | ALA1217009 | F | Antimicrobial activity against Leishmania donovani | Leishmania donovani | 287 | organism-based format | Scientific Literature | ||
16. | ALA1228266 | F | Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay | Toxoplasma gondii | 16 | organism-based format | Scientific Literature | ||
17. | ALA1264574 | F | Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay | Toxoplasma gondii | 13 | organism-based format | Scientific Literature | ||
18. | ALA1264575 | F | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay | Toxoplasma gondii | 13 | organism-based format | Scientific Literature | ||
19. | ALA1264576 | F | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay | Toxoplasma gondii | 13 | organism-based format | Scientific Literature | ||
20. | ALA1264577 | F | Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay | Toxoplasma gondii | 13 | organism-based format | Scientific Literature |